(Q43289814)
Statements
1 reference
Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes (English)
1 reference
Christiane Damgé
1 reference
Marie Socha
1 reference
Nathalie Ubrich
1 reference
Philippe Maincent
1 reference
1 February 2010
1 reference
1 reference
99
1 reference
2
1 reference
879-889
1 reference